Late Referral to the Nephrologist in Outpatients Consultations
DOI:
https://doi.org/10.70108/nefrologiapy.2023.1.1.22Keywords:
chronic kidney disease, stages, proteinuria, clearance, referral, diabetes mellitusAbstract
Introduction: Chronic Kidney Disease presents a global prevalence of 10-15% on the rise. Referral to the nephrologist in the late stages is a problem for patients with this pathology. Objective: to verify in which stages of Chronic Kidney Disease the patients arrived at the consultation.
Methodology: Three hundred medical records of patients who consulted in the Renal Health Program of the National Institute of Nephrology were analyzed. For the statistical analyses, Excel Software, Student‘s T, Standard Deviation, and Percentages were used.
Results: The average age was 54.12 ± 16.45. 180 (60%) patients were female and 120 (40%) were male. The most frequent reason for consultation was control 199 (66.3%), the most frequent etiology 170 (56.6%) was diabetes mellitus, the average creatinine was 1.5 mg/dl (± 1.3), the proteinuria found was 846.6 ± 1627.3; creatinine clearance was 74.6 ± 46.5; the average stage in the consultation was 2.1 ± 1.3. Separating the population by sex, it was found that there was a difference in men‘s creatinine 1.9mg/dl± 1.6 vs 1.2mg/dl ± 0.9 women (P<0.0001); in the clearance men 64.99 ± 38.51ml/min vs women 80.17 ± 50.2 ml/min(P<0.005). The stage in men 2.3 ± 1.4 vs 1.9 ± 1.3 women (P< 0.001).
Conclusion: The main reason for which the patients consulted was for control, the most common etiology was Diabetes Mellitus. Regarding the stage in which the patients consulted, it was found that the majority were in the initial stage of kidney disease. In the division made by sex, men consulted at a later stage, had worse clearance and more proteinuria. These results are encouraging, they show that patients are referred to the nephrologist in the early stages of kidney disease, which will allow better follow-up, thereby reducing the morbidity and mortality of patients, on the other hand, more emphasis should be placed on education and awareness of the male population, regarding this disease.
Downloads
Metrics
References
(1) Arredondo A. Análisis y Reflexión sobre Modelos Teóricos del Proceso Salud-Enfermedad. Health-Disease Process.Cad. Saúde Públ., Rio de Janeiro, 1992, 8(3), 254-261.
(2) Hernandez C. (2012). Modelos conceptuales y paradigmas en salud pública. Revista de Salud Pública, 2012 14(2), 315-324.
(3) Ashton J. Ciudades Sanas. Barcelona. Editorial Masson, Barcelona; 1993
(4) Franco A.Tendenciasyteoríasensaludpública.Revista Facultad Nacional Salud Publica, 2006 24(2), 119-129.
(5) National Kidney Fundation. (2013). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Suple- ments, 3(1).
(6) Levey AS, de Jong S. (2011). The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney International, 80(1), 17-28. https://doi.org/10.1038/ki.2010.483
(7) Zhang QL., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health, 2008, 8(1), 117. https://doi.org/10.1186/1471-2458-8-117
(8) Otero A, Franciso ALM de, Gayoso P. Prevalence of chronic renal disease in Spain: Results of the EPIRCE study. 2020. 30(1), 78-86.
(9) Gorostidi M, Sánchez-Martínez M. Prevalencia de enfermedad renal crónica en España: Impacto de la acumulación de factores de riesgo cardiovascular. Nefrología, 2018, 38(6), 606-615. https://doi.org/10.1016/j.nefro.2018.04.004
(10) Barreto RS. (2016). Detección de enfermedad renal crónica oculta en pacientes de las Unidades de Salud Familiar de Loma Pyta. Rev. Salud Pública Parag. 2016; Vol. 6 Nº 1; Enero-Junio(37-43).
(11) Sarnak, M. J. (2003). Cardiovascular complications in chronic kidney disease. American Journal of Kidney Diseases, 41, 11-17. https://doi.org/10.1016/S0272-6386(03) 00372-X
(12) Coresh, J., Heerspink, H. (2019). Change in albuminuria and subsequent risk of end-stage kidney disease: An individual participant-level consortium meta-analysis of observational studies. The Lancet Diabetes & Endocrinology, 7(2), 115-127. https://doi.org/10.1016 S2213-8587(18)30313-9.
(13) Cueto-Manzano A. (s. f.). La Sociedad Latino- americana de Nefrología e hipertensión y los retos de la Enfermedad crónica en nuestra región. Nefrología Latinoamericana 2019; 16(1)
(14) García-Trabanino R. Nefropatía mesoamericana: Revisión breve basada en el segundo taller del Consorcio para el estudio de la Epidemia de Nefropatía en Centro- américa y México (CENCAM). Nefrología Latino- americana, 2017; 14(1), 39-45. https://doi.org/10.1016/ j.nefrol.2016.11.001
(15) Cabrera JWE, Vervaet BAC, Santa-Cruz F, De Broe ME. (2022). Chronic Interstitial Nephritis in Agricultural Communities: A Patient in Paraguay. Kidney International Reports, 7(5), 1131-1135. https://doi. org/10.1016/j.ekir.2022.02.019
(16) Benitez Triana. (s. f.). Remisión precoz vs remisión tardía de los pacientes con enfermedad renal crónica que inician hemodiálisis. Acta méd centro vol.16 no.1 Santa C Clara ene.-mar. 2022 Epub 31-Mar-2022
(17) Chan C, Blankestijn CT. Dialysis initiation, modality choice, access, and prescription: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 96(1), 37-47. https://doi.org/10.1016/j.kint.2019.01.017
(18) Fried Linda P & Tangen Catherine. Frailty in Older Adults: Evidence for a Phenotype. Journal of Gerontology: MEDICAL SCIENCES 2001, 56 A(3), 146-156.
(19) Chowdhury, R., Peel, N. M., Krosch, M., & Hubbard, R. E. (2017). Frailty and chronic kidney disease: A systematic review. Archives of Gerontology and Geriatrics, 2017; 68, 135-142. https://doi.org/10.1016/j.archger.2016.10.007.
(20) Chan, M. R., Dall, A. T., Fletcher, K. E. Outcomes in Patients with Chronic Kidney Disease Referred Late to Nephrologists: A Meta-analysis. The American Journal of Medicine, 120(12), 1063-1070.e2. https://doi.org/10.1016/j. amjmed.2007.04.024
(21) Huisman, R. M. (2004). The deadly risk of late referral. Nephrology Dialysis Transplantation, 2004; 19(9), 2175- 2180. https://doi.org/10.1093/ndt/gfh409
(22) Roubicek, C., Brunet. (2000). Timing of nephrology referral: Influence on mortality and morbidity. American Journal of Kidney Diseases, 36(1), 35-41. https://doi.org/10.1053/ajkd.2000.8241
(23) Grams, M. E., Sang, . (2018). Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney International, 93(6), 1442-1451. https://doi.org/10.1016/j. kint.2018.01.009.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pablo Alfonso Jara Linares, Evelyn Noemí Alcaraz, Natalia Noemí Giménez Lewchuk, Regina Susana Barreto Romero
This work is licensed under a Creative Commons Attribution 4.0 International License.